ZOLL Medical (ZOLL -24%) gets crushed after revealing it's facing a potential revision by...
ZOLL Medical (ZOLL -24%) gets crushed after revealing it's facing a potential revision by Medicare over how much it will pay to cover the cost of the company's defibrillators, including its LiveVest product. The outlined cuts could have "a material adverse effect on its LifeVest business," the company says.
From other sites
at CNBC.com (Apr 19, 2012)
at CNBC.com (Mar 12, 2012)
at CNBC.com (Jun 25, 2010)
at CNBC.com (Jun 7, 2010)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs